Luminous Ventures

Luminous Ventures is a London-based early-stage deep tech venture capital fund that spun out of White Cloud Capital in December 2018 with a $30 million fund. The firm focuses on the application of innovative technologies to healthcare, life sciences, nutrition, food, and agriculture, investing at seed and Series A stages across Europe and North America. Luminous prefers to be the first venture investor in its portfolio companies, backing visionary founders with scientifically grounded breakthroughs at the earliest stages of company formation. Partner Izzy Fox leads the investment team. The fund is now fully deployed and is no longer making new investments. The portfolio of approximately 27 companies spans healthtech, AI, biotech, and food and agriculture. Named portfolio companies include Astroscreen (disinformation detection), Ellipsis Health (mental health voice AI), Hadean (high-performance cloud operating systems), Optellum (AI-based lung cancer diagnostics), Synthace (lab operating systems), Universal Quantum (quantum computing), OVR Health (VR health applications), Vital Bio (point-of-care diagnostics), and Facesoft (sustainable textile face coverings). BioBeats, an earlier portfolio company, was acquired by Huma in April 2020. The fund's most recent investment was Treos Bio in April 2024. Luminous Ventures' thesis was built on the convergence of computational power, biological understanding, and materials science — investing ahead of when these disciplines became mainstream VC themes. The firm prioritized backing founders with credible scientific backgrounds working on problems where technology could fundamentally change outcomes in health and food systems, rather than incremental software applications at the margins of these sectors.